Overview

Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder

Status:
Terminated
Trial end date:
2019-08-19
Target enrollment:
Participant gender:
Summary
This study aims to determine whether the GeneSight Psychotropic test can result in better treatment outcomes for patients with treatment-naive major depressive disorder
Phase:
Phase 4
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
AssureRx Health, Inc.
Treatments:
Antidepressive Agents
Antipsychotic Agents
Psychotropic Drugs